130 related articles for article (PubMed ID: 24661467)
1. Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians.
Mestre TA; Teodoro T; Reginold W; Graf J; Kasten M; Sale J; Zurowski M; Miyasaki J; Ferreira JJ; Marras C
Parkinsonism Relat Disord; 2014 Jun; 20(6):608-12. PubMed ID: 24661467
[TBL] [Abstract][Full Text] [Related]
2. Survey on general knowledge on Parkinson's disease in patients with Parkinson's disease and current clinical practice for Parkinson's disease among general neurologists from Southwest China.
Li J; Chen D; Song W; Chen K; Cao B; Huang R; Yang R; Shang H
Clin Neurol Neurosurg; 2014 Mar; 118():16-20. PubMed ID: 24529223
[TBL] [Abstract][Full Text] [Related]
3. Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study.
Tinazzi M; Abbruzzese G; Antonini A; Ceravolo R; Fabbrini G; Lessi P; Barone P;
Parkinsonism Relat Disord; 2013 Dec; 19(12):1130-5. PubMed ID: 23993249
[TBL] [Abstract][Full Text] [Related]
4. Initiation of medications for Parkinson's disease: a qualitative description.
Shin JY; Habermann B
J Clin Nurs; 2016 Jan; 25(1-2):127-33. PubMed ID: 26420046
[TBL] [Abstract][Full Text] [Related]
5. The effects of clinical motor variables and medication dosage on working memory in Parkinson's disease.
Moustafa AA; Bell P; Eissa AM; Hewedi DH
Brain Cogn; 2013 Jul; 82(2):137-45. PubMed ID: 23660434
[TBL] [Abstract][Full Text] [Related]
6. Requirements for Parkinson's disease pharmacotherapy from the patients' perspective: a questionnaire-based survey.
Wüllner U; Fuchs G; Reketat N; Randerath O; Kassubek J
Curr Med Res Opin; 2012 Jul; 28(7):1239-46. PubMed ID: 22686959
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
Rascol O; Fitzer-Attas CJ; Hauser R; Jankovic J; Lang A; Langston JW; Melamed E; Poewe W; Stocchi F; Tolosa E; Eyal E; Weiss YM; Olanow CW
Lancet Neurol; 2011 May; 10(5):415-23. PubMed ID: 21482191
[TBL] [Abstract][Full Text] [Related]
8. Othello syndrome in patients with Parkinson's disease.
Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
[TBL] [Abstract][Full Text] [Related]
9. [Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
Bailbé M; Karolewicz S; Neau JP; Dumas P; Gil R;
Rev Neurol (Paris); 2002 Feb; 158(2):203-10. PubMed ID: 11965176
[TBL] [Abstract][Full Text] [Related]
10. The sensitivity and specificity of the 9-item Wearing-off Questionnaire.
Stacy MA; Murphy JM; Greeley DR; Stewart RM; Murck H; Meng X;
Parkinsonism Relat Disord; 2008; 14(3):205-12. PubMed ID: 17900967
[TBL] [Abstract][Full Text] [Related]
11. Socio-demographic and clinical factors influencing the adherence to treatment in Parkinson's disease: the ADHESON study.
Valldeoriola F; Coronell C; Pont C; Buongiorno MT; Cámara A; Gaig C; Compta Y;
Eur J Neurol; 2011 Jul; 18(7):980-7. PubMed ID: 21199185
[TBL] [Abstract][Full Text] [Related]
12. Insulin therapy attitudes and beliefs of physicians in Middle Eastern Arab countries.
Lakkis NA; Maalouf GJ; Mahmassani DM; Hamadeh GN
Fam Pract; 2013 Oct; 30(5):560-7. PubMed ID: 23729488
[TBL] [Abstract][Full Text] [Related]
13. [Insufficient medication compliance in Parkinson's disease].
Aerts MB; van der Eijk M; Kramers K; Bloem BR
Ned Tijdschr Geneeskd; 2011; 155():A3031. PubMed ID: 21527053
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).
Fleisher JE; Dahodwala NA; Xie SX; Mayo M; Weintraub D; Chodosh J; Shea JA
J Parkinsons Dis; 2016 Apr; 6(2):383-92. PubMed ID: 27061070
[TBL] [Abstract][Full Text] [Related]
15. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
[TBL] [Abstract][Full Text] [Related]
17. [Early treatment of Parkinson's disease with levodopa].
Odekerken VJ; Post B; Verschuur CV; de Bie RM
Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822
[TBL] [Abstract][Full Text] [Related]
18. Prescribing pattern in Parkinson's disease: are cost and efficacy overriding factors?
Tan EK; Yeo AP; Tan V; Pavanni R; Wong MC
Int J Clin Pract; 2005 May; 59(5):511-4. PubMed ID: 15857344
[TBL] [Abstract][Full Text] [Related]
19. Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease.
Wang MT; Lian PW; Yeh CB; Yen CH; Ma KH; Chan AL
Mov Disord; 2011 Aug; 26(9):1663-9. PubMed ID: 21630354
[TBL] [Abstract][Full Text] [Related]
20. Action naming in Parkinson's disease patients on/off dopamine.
Herrera E; Cuetos F
Neurosci Lett; 2012 Apr; 513(2):219-22. PubMed ID: 22387157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
